The company was impressed by many proven case studies on the ValGenesis VLMS’s ability to significantly reduce validation cycle time while enabling audit-ready processes.
News
News
_________________
Leading T-cell immunotherapy company selects ValGenesis VLMS
March 2, 2020 | Comprehensive and easily configurable, the VLMS is a cloud-based, SaaS, end-to-end validation lifecycle management system with powerful collaborative, risk-based, and change management functionalities that enable swift and audit-ready processes at enterprise level.
2020
February
January
After evaluating multiple validation software solutions available in the market, the company selected ValGenesis VLMS – a single, end-to-end solution that can manage the entire validation lifecycle process.
2019
December
Today, in addition to the scope of automating and managing this company’s EQ, CSV, cleaning and process validation lifecycle processes, ValGenesis will enable a robust prediction and intelligence forecasting mechanism through the VLMS.
Facing inefficiencies and delays in a paper-based validation approach, the company evaluated and selected ValGenesis's VLMS - a cloud-based SaaS solution to manage its validation lifecycle, to meet stringent regulatory standards in the biomedical industry.
November
With robust flexibility, web services, and scalability tools built into the core solution, ValGenesis's VLMS easily integrates with other software systems to provide seamless, end-to-end validation lifecycle management.
Describing ValGenesis's end-to-end validation lifecycle management system with comprehensive risk management, trace matrix, and change management functionalities as "powerful," the company has digitized their CSV process through ValGenesis VLMS and plans to expand its use to a 100% paperless process for equipment validation soon.
October
ValGenesis, Inc., announced a technology partnership with T-Systems North America in its effort to help the Life Science sector's transformation to Industrial Internet of Things (IIoT) Technology, which is becoming extremely critical in pharmaceutical and biotech manufacturing where sub-optimal environmental conditions have often lead to noncompliance.
Keen to start creating leaner, more efficient Computer System Validation (CSV) processes, the company had evaluated multiple solutions before selecting ValGenesis Enterprise VLMS—a cloud-based SaaS solution that enables rigorous compliance, improves process consistency, facilitates standardization and significantly reduces validation cycle time.
ValGenesis has aggressively expanded its presence globally, successfully forging partnerships with several life science companies, helping them migrate from manual paper-based validation processes to 100% paperless validation. The new subsidiary in Canada will further accelerate and support this growth by providing a strategic vantage point for engagement with the region’s largest pharmaceutical and life science companies.
